Guggenheim Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-227,415
Closed -$41.8M 2273
2021
Q2
$41.8M Sell
227,415
-7,184
-3% -$1.32M 0.25% 64
2021
Q1
$35.9M Sell
234,599
-40,305
-15% -$6.16M 0.24% 67
2020
Q4
$43M Sell
274,904
-40,409
-13% -$6.31M 0.27% 57
2020
Q3
$36.1M Sell
315,313
-28,570
-8% -$3.27M 0.26% 64
2020
Q2
$38.6M Buy
343,883
+41,048
+14% +$4.61M 0.3% 55
2020
Q1
$27.2M Sell
302,835
-10,663
-3% -$957K 0.27% 67
2019
Q4
$33.9M Buy
313,498
+3,378
+1% +$365K 0.25% 68
2019
Q3
$30.4M Buy
310,120
+11,445
+4% +$1.12M 0.24% 76
2019
Q2
$39.1M Buy
298,675
+5,438
+2% +$712K 0.32% 47
2019
Q1
$39.6M Buy
293,237
+58,483
+25% +$7.91M 0.32% 46
2018
Q4
$22.9M Sell
234,754
-17,082
-7% -$1.66M 0.19% 83
2018
Q3
$35M Buy
251,836
+1,592
+0.6% +$221K 0.23% 54
2018
Q2
$31.1M Sell
250,244
-322,407
-56% -$40M 0.21% 66
2018
Q1
$63.8M Sell
572,651
-41,992
-7% -$4.68M 0.16% 180
2017
Q4
$73.5M Buy
614,643
+166,839
+37% +$20M 0.17% 134
2017
Q3
$62.8M Sell
447,804
-107,539
-19% -$15.1M 0.15% 165
2017
Q2
$67.6M Buy
555,343
+124,968
+29% +$15.2M 0.18% 127
2017
Q1
$52.2M Buy
430,375
+28,129
+7% +$3.41M 0.14% 245
2016
Q4
$49.2M Sell
402,246
-92,435
-19% -$11.3M 0.14% 232
2016
Q3
$60.6M Buy
494,681
+54,377
+12% +$6.66M 0.19% 90
2016
Q2
$51.4M Sell
440,304
-867
-0.2% -$101K 0.16% 152
2016
Q1
$61.4M Sell
441,171
-25,880
-6% -$3.6M 0.19% 92
2015
Q4
$89.1M Sell
467,051
-141,908
-23% -$27.1M 0.26% 38
2015
Q3
$95.2M Sell
608,959
-40,684
-6% -$6.36M 0.29% 22
2015
Q2
$117M Buy
649,643
+28,834
+5% +$5.21M 0.29% 17
2015
Q1
$108M Buy
620,809
+95,623
+18% +$16.6M 0.25% 26
2014
Q4
$97.2M Buy
525,186
+100,204
+24% +$18.5M 0.24% 42
2014
Q3
$70.5M Sell
424,982
-146,215
-26% -$24.2M 0.17% 97
2014
Q2
$89.3M Buy
571,197
+15,058
+3% +$2.35M 0.23% 44
2014
Q1
$84.6M Buy
556,139
+155,185
+39% +$23.6M 0.24% 43
2013
Q4
$53.4M Sell
400,954
-110,662
-22% -$14.7M 0.16% 116
2013
Q3
$59.4M Buy
511,616
+133,752
+35% +$15.5M 0.21% 55
2013
Q2
$34.9M Buy
+377,864
New +$34.9M 0.15% 119